Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor × MK-4166 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

senaparib 7 pembrolizumab 7 Irinotecan 6 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Capecitabine 5 Nivolumab 4 Fluorouracil 4 Bevacizumab 4 Rifampin 3 Midazolam 3 Leucovorin 3 Itraconazole 3 Injections 3 pertuzumab 2 ontuxizumab 2 navoximod 2 atezolizumab 2 Gemcitabine 2 vofatamab 1 tremelimumab 1 trastuzumab duocarmazine 1 talazoparib 1 sotorasib 1 sintilimab 1 saracatinib 1 rucaparib 1 ridaforolimus 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡